Mesenchymal stem cell therapy in proteoglycan induced arthritis

MLA

Infection & Immunity, et al. Mesenchymal Stem Cell Therapy in Proteoglycan Induced Arthritis. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1395328232&authtype=sso&custid=ns315887.

APA

Infection & Immunity, Risk Assessment, dI&I RA-I&I I&I, LS Immunologie, Swart, J. F., de Roock, S., Hofhuis, F. M., Rozemuller, H., van den Broek, T., Moerer, P., Broere, F., van Wijk, F., Kuis, W., Prakken, B. J., Martens, a. c. ., & Wulffraat, N. M. (2015). Mesenchymal stem cell therapy in proteoglycan induced arthritis.

Chicago

Infection & Immunity, Risk Assessment, dI&I RA-I&I I&I, LS Immunologie, J. F. Swart, S. de Roock, F. M. Hofhuis, et al. 2015. “Mesenchymal Stem Cell Therapy in Proteoglycan Induced Arthritis.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1395328232&authtype=sso&custid=ns315887.